CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 500 filers reported holding CRISPR THERAPEUTICS AG in Q2 2021. The put-call ratio across all filers is 1.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $287,908 | -24.5% | 6,343 | -6.7% | 0.00% | -100.0% |
Q2 2023 | $381,471 | +11.7% | 6,795 | -10.0% | 0.00% | 0.0% |
Q1 2023 | $341,487 | +21.9% | 7,550 | +9.6% | 0.00% | – |
Q4 2022 | $280,118 | -67.8% | 6,891 | -48.3% | 0.00% | -100.0% |
Q3 2022 | $870,000 | +63.2% | 13,316 | +51.9% | 0.00% | +100.0% |
Q2 2022 | $533,000 | -10.9% | 8,767 | -8.0% | 0.00% | 0.0% |
Q1 2022 | $598,000 | -9.0% | 9,526 | +10.0% | 0.00% | 0.0% |
Q4 2021 | $657,000 | -18.4% | 8,660 | +20.3% | 0.00% | -50.0% |
Q3 2021 | $805,000 | -14.7% | 7,196 | +23.5% | 0.00% | 0.0% |
Q2 2021 | $944,000 | +48.0% | 5,829 | +11.5% | 0.00% | +100.0% |
Q1 2021 | $638,000 | +230.6% | 5,230 | +316.1% | 0.00% | – |
Q4 2020 | $193,000 | +93.0% | 1,257 | +5.2% | 0.00% | – |
Q3 2020 | $100,000 | -40.8% | 1,195 | -47.9% | 0.00% | – |
Q2 2020 | $169,000 | +74.2% | 2,295 | 0.0% | 0.00% | – |
Q1 2020 | $97,000 | -26.5% | 2,295 | +5.8% | 0.00% | – |
Q4 2019 | $132,000 | +1785.7% | 2,170 | +1176.5% | 0.00% | – |
Q3 2019 | $7,000 | -75.9% | 170 | -72.6% | 0.00% | – |
Q2 2019 | $29,000 | +866.7% | 621 | +553.7% | 0.00% | – |
Q1 2019 | $3,000 | 0.0% | 95 | 0.0% | 0.00% | – |
Q4 2018 | $3,000 | -25.0% | 95 | 0.0% | 0.00% | – |
Q3 2018 | $4,000 | +300.0% | 95 | +143.6% | 0.00% | – |
Q1 2017 | $1,000 | – | 39 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Gilfoyle Management LLC | 150 | $6,376 | 12.96% |
Versant Venture Management, LLC | 498,558 | $22,629,548 | 12.03% |
NEA Management Company, LLC | 1,587,854 | $72,072,693 | 5.57% |
ARK Investment Management | 7,163,118 | $325,133,913 | 2.49% |
Nikko Asset Management Americas, Inc. | 3,465,470 | $157,263,029 | 1.88% |
Integral Health Asset Management, LLC | 275,000 | $12,482,250 | 1.73% |
Merlin Capital, Inc | 9,092 | $412,686 | 1.54% |
Del-Sette Capital Management, LLC | 33,977 | $1,542,216 | 1.52% |
Green Alpha Advisors, LLC | 34,880 | $1,583,203 | 1.22% |
Ikarian Capital, LLC | 2,039 | $9,255,021 | 1.11% |